Fig. 1: Clinical course during the treatment.
From: A case of Dravet syndrome with a novel SCN1A gross deletion involving the promoter region
A After the age of 2 years, the patient was started on VPA- and FFA-targeted therapy, which showed effectiveness in controlling seizures provoked by fever. B Plain head computed tomography at the time of admission revealed no abnormalities and calcification. C An interictal electroencephalogram showed no abnormalities in background activity during wakefulness as well as no epileptiform abnormalities during either wakefulness or sleep.
